Title: Performance of strip-based glucose meters and cassette-based blood gas analyzer for monitoring glucose levels in a surgical intensive care setting
Authors: Claerhout, Helena
De Prins, Martine
Mesotten, Dieter
Van den Berghe, Greet
Mathieu, Chantal
Van Eldere, Johan
Vanstapel, Florent # ×
Issue Date: 2015
Publisher: Walter de Gruyter
Series Title: Clinical Chemistry and Laboratory Medicine
Abstract: BACKGROUND: We verified the analytical performance of strip-based hand-held glucose meters (GM) for prescription use, in a comparative split-sample protocol using blood gas samples from a surgical intensive care unit (ICU).
METHODS: Freestyle Precision Pro (Abbott), StatStrip Connectivity Meter (Nova), ACCU-CHEK Inform II (Roche) were evaluated for recovery/linearity, imprecision/repeatability. The GM’s and the ABL90 (Radiometer) blood gas analyzer (BGA) were tested for relative accuracy versus the comparator hexokinase glucose-6-phosphate-dehydrogenase (HK/G6PDH) assay on a Cobas c702 analyzer (Roche).
RESULTS: Recovery of spiked glucose was linear up to 19.3 mmol/L (347 mg/dL) with a slope of 0.91-0.94 for all GM’s. Repeatability estimated by pooling duplicate measurements on samples below (n=9), in (n=51) or above (n=80) the 4.2-5.9 mM (74-106 mg/dL) range were for Freestyle Precision Pro: 4.2%, 4.0%, 3.6%; StatStrip Connectivity Meter: 4.0%, 4.3%, 4.5%; and ACCU-CHEK Inform II: 1.4%, 2.5%, 3.5%. GM’s were in agreement with the comparator method. The BGA outperformed the GM’s, with a MARD of 3.9% compared to 6.5%, 5.8% and 4.4% for the FreeStyle, StatStrip and ACCU-CHEK, respectively. Zero % of the BGA results deviated more than the FDA 10% criterion as compared to 9.4%, 3.7% and 2.2% for the FreeStyle, StatStrip and ACCU-CHEK, respectively. For all GM’s, icodextrin did not interfere. Variation in the putative influence factors hematocrit and O2 tension could not explain observed differences with the comparator method.
CONCLUSION: GM’s quantified blood glucose in whole blood at about the 10% total error criterion, proposed by the FDA for prescription use.
ISSN: 1434-6621
Publication status: accepted
KU Leuven publication type: IT
Appears in Collections:Department of Health and Technology - UC Leuven
Laboratory of Clinical Bacteriology and Mycology
Clinical and Experimental Endocrinology
Laboratory of Intensive Care Medicine
Biomedical Quality Assurance Research Unit
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science